236 related articles for article (PubMed ID: 21933852)
1. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
Jacquemin G; Granci V; Gallouet AS; Lalaoui N; Morlé A; Iessi E; Morizot A; Garrido C; Guillaudeux T; Micheau O
Haematologica; 2012 Jan; 97(1):38-46. PubMed ID: 21933852
[TBL] [Abstract][Full Text] [Related]
2. Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.
Premkumar DR; Jane EP; Foster KA; Pollack IF
J Pharmacol Exp Ther; 2013 Aug; 346(2):201-10. PubMed ID: 23740602
[TBL] [Abstract][Full Text] [Related]
3. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.
Spagnuolo C; Cerella C; Russo M; Chateauvieux S; Diederich M; Russo GL
Br J Cancer; 2011 Jul; 105(2):221-30. PubMed ID: 21750559
[TBL] [Abstract][Full Text] [Related]
4. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
5. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
Siegelin MD; Reuss DE; Habel A; Rami A; von Deimling A
Neuro Oncol; 2009 Apr; 11(2):122-31. PubMed ID: 18971417
[TBL] [Abstract][Full Text] [Related]
6. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.
Wang X; Chen W; Zeng W; Bai L; Tesfaigzi Y; Belinsky SA; Lin Y
Mol Cancer Ther; 2008 May; 7(5):1156-63. PubMed ID: 18483303
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
Gillissen B; Wendt J; Richter A; Richter A; Müer A; Overkamp T; Gebhardt N; Preissner R; Belka C; Dörken B; Daniel PT
J Cell Biol; 2010 Mar; 188(6):851-62. PubMed ID: 20308427
[TBL] [Abstract][Full Text] [Related]
8. Quercetin-3-O-(2"-galloyl)-α-l-rhamnopyranoside prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway.
Kim YJ; Jung EB; Seo SJ; Park KH; Lee MW; Lee CS
Chem Biol Interact; 2013 Aug; 204(3):144-52. PubMed ID: 23711929
[TBL] [Abstract][Full Text] [Related]
9. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
10. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
Weng C; Li Y; Xu D; Shi Y; Tang H
J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055
[TBL] [Abstract][Full Text] [Related]
11. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.
Kim YH; Lee DH; Jeong JH; Guo ZS; Lee YJ
Biochem Pharmacol; 2008 May; 75(10):1946-58. PubMed ID: 18377872
[TBL] [Abstract][Full Text] [Related]
12. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells.
Sarif Z; Tolksdorf B; Fechner H; Eberle J
Mol Carcinog; 2020 Nov; 59(11):1256-1268. PubMed ID: 32885857
[TBL] [Abstract][Full Text] [Related]
13. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin.
Lee DH; Lee CS; Kim DW; Ae JE; Lee TH
Anticancer Drugs; 2014 Jan; 25(1):44-52. PubMed ID: 24045365
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.
Siegelin MD; Reuss DE; Habel A; Herold-Mende C; von Deimling A
Mol Cancer Ther; 2008 Nov; 7(11):3566-74. PubMed ID: 19001439
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.
Martínez-Paniagua MA; Baritaki S; Huerta-Yepez S; Ortiz-Navarrete VF; González-Bonilla C; Bonavida B; Vega MI
Cell Cycle; 2011 Aug; 10(16):2792-805. PubMed ID: 21822052
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.
Lincoln FA; Imig D; Boccellato C; Juric V; Noonan J; Kontermann RE; Allgöwer F; Murphy BM; Rehm M
Cell Death Dis; 2018 Nov; 9(11):1112. PubMed ID: 30385739
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis.
Unterkircher T; Cristofanon S; Vellanki SH; Nonnenmacher L; Karpel-Massler G; Wirtz CR; Debatin KM; Fulda S
Clin Cancer Res; 2011 Jun; 17(12):4019-30. PubMed ID: 21525171
[TBL] [Abstract][Full Text] [Related]
18. TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1.
Son JK; Varadarajan S; Bratton SB
Cell Death Differ; 2010 Aug; 17(8):1288-301. PubMed ID: 20168333
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
20. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53.
Soini Y; Raunio H; Pääkkö P
Tumour Biol; 1998; 19(3):176-85. PubMed ID: 9591044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
